Phillip M. Tharnish

1.5k total citations
30 papers, 1.3k citations indexed

About

Phillip M. Tharnish is a scholar working on Infectious Diseases, Hepatology and Epidemiology. According to data from OpenAlex, Phillip M. Tharnish has authored 30 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 14 papers in Hepatology and 12 papers in Epidemiology. Recurrent topics in Phillip M. Tharnish's work include HIV/AIDS drug development and treatment (16 papers), Hepatitis C virus research (14 papers) and Biochemical and Molecular Research (9 papers). Phillip M. Tharnish is often cited by papers focused on HIV/AIDS drug development and treatment (16 papers), Hepatitis C virus research (14 papers) and Biochemical and Molecular Research (9 papers). Phillip M. Tharnish collaborates with scholars based in United States, Czechia and Argentina. Phillip M. Tharnish's co-authors include Raymond F. Schinazi, Michaël Otto, Lieven Stuyver, Tamara R. McBrayer, Stefania Lostia, Phillip A. Furman, Kyoichi A. Watanabe, Chung K. Chu, Junxing Shi and Tony Whitaker and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Virology and Journal of Medicinal Chemistry.

In The Last Decade

Phillip M. Tharnish

30 papers receiving 1.2k citations

Peers

Countries citing papers authored by Phillip M. Tharnish

Since Specialization

Citations

This map shows the geographic impact of Phillip M. Tharnish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip M. Tharnish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip M. Tharnish more than expected).

Fields of papers citing papers by Phillip M. Tharnish

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip M. Tharnish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip M. Tharnish. The network helps show where Phillip M. Tharnish may publish in the future.

Co-authorship network of co-authors of Phillip M. Tharnish

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip M. Tharnish. A scholar is included among the top collaborators of Phillip M. Tharnish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip M. Tharnish. Phillip M. Tharnish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthesis and biological evaluation of new potent and selective HCV NS5A inhibitors 2012 ·Bioorganic & Medicinal Chemistry Letters ·Junxing Shi, Longhu Zhou, Franck Amblard, (unknown), Hongwang Zhang, Peng Liu, (unknown), Tamara R. McBrayer, Phillip M. Tharnish, Tony Whitaker, Steven J. Coats, Raymond F. Schinazi	19
2	Synthesis and evaluation of novel potent HCV NS5A inhibitors 2012 ·Bioorganic & Medicinal Chemistry Letters ·Hongwang Zhang, Longhu Zhou, Franck Amblard, Junxing Shi, (unknown), Sijia Tao, Tamara R. McBrayer, Phillip M. Tharnish, Tony Whitaker, Steven J. Coats, Raymond F. Schinazi	11
3	Synthesis of purine modified 2′-C-methyl nucleosides as potential anti-HCV agents 2011 ·Bioorganic & Medicinal Chemistry Letters ·Hongwang Zhang, Longhu Zhou, Steven J. Coats, Tamara R. McBrayer, Phillip M. Tharnish, (unknown), Mervi Detorio, (unknown), (unknown), Tony Whitaker, Raymond F. Schinazi	13
4	Antiviral activity and tolerability of amdoxovir with zidovudine in a randomized double-blind placebo-controlled study in HIV-1-infected individuals 2010 ·Antiviral Therapy ·Robert L. Murphy, (unknown), Carlos Zala, (unknown), Phillip M. Tharnish, Judy S. Mathew, (unknown), Raymond F. Schinazi	11
5	Lack of Pharmacokinetic Interaction between Amdoxovir and Reduced- and Standard-Dose Zidovudine in HIV-1-Infected Individuals 2009 ·Antimicrobial Agents and Chemotherapy ·Selwyn J. Hurwitz, Ghazia Asif, Emilie Fromentin, Phillip M. Tharnish, Raymond F. Schinazi	6
6	Anti-hepatitis C Virus Activity of Novel β-D-2′-C-methyl-4′-azido Pyrimidine Nucleoside Phosphoramidate Prodrugs 2009 ·Antiviral chemistry & chemotherapy ·(unknown), Steven J. Coats, Tamara R. McBrayer, (unknown), (unknown), Phillip M. Tharnish, Tony Whitaker, Longhu Zhou, Raymond F. Schinazi	24
7	Synthesis and Biological Activity of 5′,9-Anhydro-3-Purine-ISONucleosides as Potential Anti-Hepatitis C Virus Agents 2006 ·Nucleosides Nucleotides & Nucleic Acids ·(unknown), Peiyuan Wang, Abdalla E. A. Hassan, Jinfa Du, Phillip M. Tharnish, Eisuke Murakami, Lieven Stuyver, Michaël Otto, Raymond F. Schinazi, Kyoichi A. Watanabe	9
8	Inhibition of Hepatitis C Replicon RNA Synthesis by β-D-2′-deoxy-2′-fluoro-2′-C-Methylcytidine: A Specific Inhibitor of Hepatitis C Virus Replication 2006 ·Antiviral chemistry & chemotherapy ·Lieven Stuyver, Tamara R. McBrayer, Phillip M. Tharnish, Jeremy L. Clark, Laurent Hollecker, Stefania Lostia, (unknown), (unknown), (unknown), Mengyu Xie, Raymond F. Schinazi, John D. Morrey, (unknown), Phillip A. Furman, Michaël Otto	91
9	Synthesis and anti-viral activity of a series of d- and l-2′-deoxy-2′-fluororibonucleosides in the subgenomic HCV replicon system 2005 ·Bioorganic & Medicinal Chemistry ·Junxing Shi, Jinfa Du, Tianwei Ma, Krzysztof W. Pankiewicz, Steven Patterson, Phillip M. Tharnish, Tamara R. McBrayer, Lieven Stuyver, Michaël Otto, Chung K. Chu, (unknown), (unknown)	38
10	Synthesis and antiviral activity of 2′-deoxy-2′-fluoro-2′-C-methyl purine nucleosides as inhibitors of hepatitis C virus RNA replication 2005 ·Bioorganic & Medicinal Chemistry Letters ·Jeremy L. Clark, Joan Mason, Laurent Hollecker, Lieven Stuyver, Phillip M. Tharnish, Tamara R. McBrayer, Michaël Otto, Phillip A. Furman, Raymond F. Schinazi, Kyoichi A. Watanabe	47
11	Synthesis of 5′,9-anhydro-3-(β-d-ribofuranosyl)xanthine, and 3,5′-anhydro-xanthosine as potential anti-hepatitis C virus agents 2005 ·Tetrahedron Letters ·(unknown), Peiyuan Wang, Abdalla E. A. Hassan, Jinfa Du, Phillip M. Tharnish, Lieven Stuyver, Michaël Otto, Raymond F. Schinazi, Kyoichi A. Watanabe	12
12	Cytostatic 6-Arylpurine Nucleosides. 6. SAR in Anti-HCV and Cytostatic Activity of Extended Series of 6-Hetarylpurine Ribonucleosides 2005 ·Journal of Medicinal Chemistry ·Michal Hocek, Petr Nauš, Radek Pohl, Ivan Votruba, Phillip A. Furman, Phillip M. Tharnish, Michaël Otto	134
13	Synthesis of N³,5‘-Cyclo-4-(β-d-ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one, a Novel Compound with Anti-Hepatitis C Virus Activity 2004 ·Journal of Medicinal Chemistry ·Peiyuan Wang, Laurent Hollecker, Krzysztof W. Pankiewicz, Steven Patterson, Tony Whitaker, Tamara R. McBrayer, Phillip M. Tharnish, Robert W. Sidwell, Lieven Stuyver, Michaël Otto, Raymond F. Schinazi, Kyoichi A. Watanabe	18
14	Manadomanzamines A and B: A Novel Alkaloid Ring System with Potent Activity against Mycobacteria and HIV-1 2003 ·Journal of the American Chemical Society ·Jiangnan Peng, Jin‐Feng Hu, (unknown), Ze Li, Mitchell A. Avery, Olivier Peraud, Russell T. Hill, Scott G. Franzblau, Fangqiu Zhang, Raymond F. Schinazi, Susan Schlueter Wirtz, Phillip M. Tharnish, Michelle Kelly, Subagus Wahyuono, Mark T. Hamann	82
15	N4-Acyl-Modified D-2′,3′-Dideoxy-5-Fluorocytidine Nucleoside Analogues with Improved Antiviral Activity 2003 ·Antiviral chemistry & chemotherapy ·Junxing Shi, Judy S. Mathew, Phillip M. Tharnish, Suguna Rachakonda, S. Balakrishna Pai, (unknown), (unknown), Karen Gallagher, Hangchun Zhang, Jingtao Wu, Guoen Shi, Romas Geleziunas, Susan Erickson‐Viitanen, Lieven Stuyver, Michaël Otto, Kyoichi A. Watanabe, Raymond F. Schinazi	3
16	Sexual transmission risk perceptions and behavioural correlates of HIV concentrations in semen 2002 ·AIDS Care ·Seth C. Kalichman, (unknown), Marjorie Cage, James Austin, Webster Luke, (unknown), Phillip M. Tharnish, (unknown), Raymond F. Schinazi	13
17	Human Immunodeficiency Virus in Semen and Plasma: Investigation of Sexual Transmission Risk Behavioral Correlates 2001 ·AIDS Research and Human Retroviruses ·Seth C. Kalichman, Marjorie Cage, (unknown), Phillip M. Tharnish, David Rompa, James Austin, Webster Luke, (unknown), Raymond F. Schinazi	33
18	Mololipids, A New Series of Anti-HIV Bromotyramine-Derived Compounds from a Sponge of the Order Verongida 2000 ·Journal of Natural Products ·Samir A. Ross, John D. Weete, Raymond F. Schinazi, Susan Schlueter Wirtz, Phillip M. Tharnish, Paul J. Scheuer, Mark T. Hamann	34
19	Enantioselective synthesis and biological evaluation of 5-o-carboranyl pyrimidine nucleosides 1999 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), Selwyn J. Hurwitz, Phillip M. Tharnish, Raymond F. Schinazi	13
20	Synthesis and Biological Evaluation of 2‘,3‘-Didehydro-2‘,3‘-dideoxy-5- fluorocytidine (D4FC) Analogues: Discovery of Carbocyclic Nucleoside Triphosphates with Potent Inhibitory Activity against HIV-1 Reverse Transcriptase 1999 ·Journal of Medicinal Chemistry ·Junxing Shi, J. Jeffrey McAtee, Susan Schlueter Wirtz, Phillip M. Tharnish, (unknown), Dennis C. Liotta, Raymond F. Schinazi	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact